Literature DB >> 3908280

Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later.

E Eschwege, J L Richard, N Thibult, P Ducimetière, J M Warnet, J R Claude, G E Rosselin.   

Abstract

The Paris Prospective Study is a long-term investigation of cardiovascular diseases in a population of 7164 working men, aged 43-54 years. The first annual follow-up session (1968-73) included a 0-2 hr 75 g OGTT with measurement of plasma insulin and glucose levels beside the major coronary heart disease (CHD) risk factors: arterial pressure, cigarette smoking, weight, cholesterol, triglycerides. After a mean 11.2 years follow-up, 651 deaths, among them 126 due to CHD, were recorded. The annual CHD mortality rates were respectively 1.4, 2.7 and 3.2 per 1000 for the 6055 normoglycaemic, 690 impaired glucose tolerance, and 293 new and known diabetic subjects (1980 WHO classification) (p less than 0.01). The annual risk was analyzed by the multivariate Cox model. It showed that the fasting plasma insulin was positively associated with risk independent of the other factors (p less than 0.05), whereas glucose tolerance, including overt diabetes, was not significantly associated. We conclude that high insulin levels may constitute a more sensitive predictor of CHD than the degree of glucose intolerance, it could be useful to avoid excessive insulin plasma concentration, and even to lower its level.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3908280

Source DB:  PubMed          Journal:  Horm Metab Res Suppl        ISSN: 0170-5903


  54 in total

Review 1.  What should we measure in the diabetic patient and how does this respond to therapy?

Authors:  Desmond G Johnston; Stephen Robinson; Shareen Forbes
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

2.  Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance.

Authors:  R W Bergstrom; D L Leonetti; L L Newell-Morris; W P Shuman; P W Wahl; W Y Fujimoto
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

Review 3.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

Review 4.  Impaired fasting glucose as a treatment target in diabetes management.

Authors:  Rene A Oliveros; Adrienne S Zion; Yelena Rosenberg; Carrie Lynn Selvaraj; Robert Chilton
Journal:  Curr Cardiol Rep       Date:  2009-11       Impact factor: 2.931

Review 5.  Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.

Authors:  Samuel Dagogo-Jack; Nonso Egbuonu; Chimaroke Edeoga
Journal:  Med Princ Pract       Date:  2010-03-29       Impact factor: 1.927

Review 6.  Diabetes and atherosclerosis. Metabolic links.

Authors:  G Steiner
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  Glucose tolerance is negatively associated with circulating progenitor cell levels.

Authors:  G P Fadini; L Pucci; R Vanacore; I Baesso; G Penno; A Balbarini; R Di Stefano; R Miccoli; S de Kreutzenberg; A Coracina; A Tiengo; C Agostini; S Del Prato; A Avogaro
Journal:  Diabetologia       Date:  2007-06-20       Impact factor: 10.122

8.  Basal insulin resistance and secretion in Nigerians with type 2 diabetes mellitus.

Authors:  J M Oli; A A Adeyemo; G O Okafor; E N Ofoegbu; B Onyenekwe; C J Chukwuka; C N Onwasigwe; S Ufelle; G Chen; C N Rotimi
Journal:  Metab Syndr Relat Disord       Date:  2009-12       Impact factor: 1.894

9.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

10.  Metabolic risk factors for cardiovascular disease in pancreas and kidney transplant recipients.

Authors:  G Nyberg; G Fager; L Mjörnstedt; M Olausson
Journal:  Diabetologia       Date:  1991-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.